Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03445390 · ClinicalTrials.gov registry record · Phase 4

The Effect of Intravenous Acetaminophen on Post-Operative Pain After Craniotomy

A Phase 4 study, sponsored by Stanford University.

Completed
Registry status
Phase 4
Development phase
27
Enrollment target

NCT03445390: Completed Phase 4 study, sponsored by Stanford University.

NCT03445390 is a Phase 4 study that has completed, run by Stanford University. The registered enrollment target is 27 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03445390, a Phase 4 study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Phase 4
Development phase
27 participants
Enrollment target

Study Summary

The purpose of the study is to determine the efficacy of IV acetaminophen when administered to neurosurgical patients at the beginning and end of their surgery. If the result is improved pain control with less opioid consumption postoperatively, then those patients may also experience less opioid related side effects such as nausea/vomiting, pruritus, and sedation. While numerous other studies have failed to show a benefit of IV acetaminophen after neurosurgical procedures, we are studying the administration of 1 g in two doses over the course of the operation.

Interventions

  • DRUG Placebo
  • DRUG Acetaminophen

Trial Details

FieldValue
Enrollment Target 27 participants
Start Date 2014-05-01
Est. Completion 2017-11-01
Phase Phase 4

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03445390

The ClinicalTrials.gov registry entry for NCT03445390 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT03445390 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03445390 about?

NCT03445390 is a clinical study titled "The Effect of Intravenous Acetaminophen on Post-Operative Pain After Craniotomy". The purpose of the study is to determine the efficacy of IV acetaminophen when administered to neurosurgical patients at the beginning and end of their surgery. If the result is improved pain control with less opioid consumption postoperatively, then those patients may also experience less opioid re...

What is the current status of trial NCT03445390?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 27 participants. The study started on 2014-05-01. Estimated completion is 2017-11-01.

What interventions are being tested in trial NCT03445390?

The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT03445390?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.